Dr Mohammed Mahmoud Youssif

PURPOSE: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality, with a high disease burden in the Middle East and North Africa (MENA) region. Multidisciplinary teams (MDTs) are essential for optimizing HCC management; however, their implementation and impact may vary across healthcare settings. This study evaluates the structure, decision-making processes, and challenges faced by MDTs in HCC treatment centers across the MENA region.

PATIENTS AND METHODS: This cross-sectional, multicenter study surveyed representatives from 53 HCC treatment centers across 38 cities in 11 MENA countries. A structured questionnaire was electronically distributed to assess MDT composition, meeting frequency, decision-making processes, adherence to clinical guidelines, patient management pathways, and challenges in HCC treatment.

RESULTS: Among the surveyed centers, 84.9% (n=45) reported having an established MDT. The most common specialties involved in MDT composition were hepatology (100%), interventional radiology (97.8%), medical oncology (91.1%), and hepatobiliary surgery (80%). Barcelona Clinic Liver Cancer staging was used in 95.6% of centers. Despite acknowledging MDT benefits, major challenges were documented by participants, including resource limitations (13.2%), financial constraints (13.2%), patient nonadherence (9.4%), and limited access to advanced technology (11.3%). Telemedicine was underutilized (9.4% of centers), and only 15.1% experienced participation in clinical trials.

CONCLUSION: Our result highlights the pivotal role of MDTs in HCC management in the MENA region, demonstrating adherence to evidence-based guidelines and exposing critical gaps in resource availability, technology integration, and patient-centered decision-making. Strengthening MDTs through enhanced resource allocation, digital health adoption, and increased clinical trial participation is essential to improving HCC outcomes in the region.

Cystic echinococcosis (CE) is a neglected zoonotic disease that causes significant economic losses in livestock and poses health risks to humans, necessitating improved diagnostic and therapeutic strategies. This study investigates CE in donkeys using a multifaceted approach that includes molecular identification, gene expression analysis, serum biochemical profiling, histopathological and immunohistochemical examination, and in vitro drug efficacy evaluation. Molecular analysis of hydatid cyst protoscolices (HC-PSCs) from infected donkey livers and lungs revealed a high similarity to Echinococcus equinus (GenBank accession: PP407081). Additionally, gene expression analysis indicated significant increases (P < 0.0001) in interleukin 1β (IL-1β) and interferon γ (IFN-γ) levels in lung and liver homogenates. Serum biochemical analysis showed elevated aspartate transaminase (AST), alkaline phosphatase (ALP), and globulin levels, alongside decreased albumin compared to non-infected controls. Histopathological examination revealed notable alterations in pulmonary and hepatic tissues associated with hydatid cyst infection. Immunohistochemical analysis showed increased expression of nuclear factor kappa B (NF-κB), tumor necrosis factor-α (TNF-α), and toll-like receptor-4 (TLR-4), indicating a robust inflammatory response. In vitro drug evaluations revealed that Paroxetine (at concentrations of 2.5, and 5 mg/mL) demonstrated the highest efficacy among repurposed drugs against HC-PSCs, resulting in the greatest cell mortality. Colmediten followed closely in effectiveness, whereas both Brufen and Ator exhibited minimal effects. This study identifies Paroxetine as a promising alternative treatment for hydatidosis and provides a framework for investigating other parasitic infections and novel therapies.

Cystic echinococcosis (CE) is a neglected zoonotic disease that causes significant economic losses in livestock and poses health risks to humans, necessitating improved diagnostic and therapeutic strategies. This study investigates CE in donkeys using a multifaceted approach that includes molecular identification, gene expression analysis, serum biochemical profiling, histopathological and immunohistochemical examination, and in vitro drug efficacy evaluation. Molecular analysis of hydatid cyst protoscolices (HC-PSCs) from infected donkey livers and lungs revealed a high similarity to Echinococcus equinus (GenBank accession: PP407081). Additionally, gene expression analysis indicated significant increases (P < 0.0001) in interleukin 1β (IL-1β) and interferon γ (IFN-γ) levels in lung and liver homogenates. Serum biochemical analysis showed elevated aspartate transaminase (AST), alkaline phosphatase (ALP), and globulin levels, alongside decreased albumin compared to non-infected controls. Histopathological examination revealed notable alterations in pulmonary and hepatic tissues associated with hydatid cyst infection. Immunohistochemical analysis showed increased expression of nuclear factor kappa B (NF-κB), tumor necrosis factor-α (TNF-α), and toll-like receptor-4 (TLR-4), indicating a robust inflammatory response. In vitro drug evaluations revealed that Paroxetine (at concentrations of 2.5, and 5 mg/mL) demonstrated the highest efficacy among repurposed drugs against HC-PSCs, resulting in the greatest cell mortality. Colmediten followed closely in effectiveness, whereas both Brufen and Ator exhibited minimal effects. This study identifies Paroxetine as a promising alternative treatment for hydatidosis and provides a framework for investigating other parasitic infections and novel therapies.

Cystic echinococcosis (CE) is a neglected zoonotic disease that causes significant economic losses in livestock and poses health risks to humans, necessitating improved diagnostic and therapeutic strategies. This study investigates CE in donkeys using a multifaceted approach that includes molecular identification, gene expression analysis, serum biochemical profiling, histopathological and immunohistochemical examination, and in vitro drug efficacy evaluation. Molecular analysis of hydatid cyst protoscolices (HC-PSCs) from infected donkey livers and lungs revealed a high similarity to Echinococcus equinus (GenBank accession: PP407081). Additionally, gene expression analysis indicated significant increases (P < 0.0001) in interleukin 1β (IL-1β) and interferon γ (IFN-γ) levels in lung and liver homogenates. Serum biochemical analysis showed elevated aspartate transaminase (AST), alkaline phosphatase (ALP), and globulin levels, alongside decreased albumin compared to non-infected controls. Histopathological examination revealed notable alterations in pulmonary and hepatic tissues associated with hydatid cyst infection. Immunohistochemical analysis showed increased expression of nuclear factor kappa B (NF-κB), tumor necrosis factor-α (TNF-α), and toll-like receptor-4 (TLR-4), indicating a robust inflammatory response. In vitro drug evaluations revealed that Paroxetine (at concentrations of 2.5, and 5 mg/mL) demonstrated the highest efficacy among repurposed drugs against HC-PSCs, resulting in the greatest cell mortality. Colmediten followed closely in effectiveness, whereas both Brufen and Ator exhibited minimal effects. This study identifies Paroxetine as a promising alternative treatment for hydatidosis and provides a framework for investigating other parasitic infections and novel therapies.

BACKGROUND
Substrate stiffness and internal pressure play key roles in mediating insect adaptability to mechanical cues through various mechanosensitive pathways. However, the involvement of mechanosensory perception in oviposition behavior of tephritid flies remains largely unexplored. Given that frugivorous tephritid flies use extraordinarily sharp-tipped ovipositors to probe the stiff fruit peel before laying eggs, we speculated that mechanosensory-responsive pathways mediate the oviposition behavior.

RESULTS
In this study, we combined oviposition assays and RNA interference (RNAi) techniques to investigate how mechanosensory pathways mediate oviposition behaviors in the notorious invasive tephritid fly, Bactrocera dorsalis. The results show that both substrate stiffness and ovarian distention influenced the oviposition decision of female flies. Furthermore, silencing the BdTMC gene impaired the ability of flies to discriminate substrate hardness, while treatment with dsBdNomPC disrupted the internal pressure balance, leading to the accumulation of eggs in the ovary. Notably, a neuropeptide, BdNPLP1 was found to be involved in mechanosensitive signal transduction downstream of BdTMC and BdNomPC.

CONCLUSIONS
Overall, our findings decipher the molecular mechanism underlying mechanosensory pathways mediating egg-laying behavior in B. dorsalis. We propose that oviposition decision-making is driven by a combination of internal and external mechanosensitive inputs, which offer new insights into the complex system of insect egg-laying regulation. © 2025 Society of Chemical Industry.

BACKGROUND: Candida albicans infection induces economic losses in aquaculture practices. Currently, the success of the nanotechnology field has gained more consideration in the aquaculture sector as it bestows favorable impacts in remedies in comparison to traditional practices.

OBJECTIVE: The present study was conducted to assess the role of nano chitosan gel (NCG) exposure via water in managing the deteriorating impacts triggered by C. albicans in Nile tilapia, Oreochromis niloticus. Hepato-renal function, behavioral and stress response, neurological function, hepatic antioxidant/oxidant status, and histopathological architectures were investigated.

METHODS: A total of 160 fish (average weight: 50.00 ± 6.30 g) were randomly assigned to four groups, each with four replicates: control, NCG, C. albicans, and NCG + C. albicans. The NCG was applied as bath treatment at a concentration of 75 µg/L for ten days.

RESULTS: The outcomes demonstrated that the C. albicans challenged fish exhibited obvious behavioral alterations including loss of equilibrium, surfacing, abnormal swimming and movement, and aggression. Infection with C. albicans caused an elevation in hepato-renal biomarkers (alanine and aspartate aminotransferases, alkaline phosphatase, urea, and creatinine), stress-related indices (glucose, cortisol, nor-epinephrine, and 8-hydroxy-2-deoxyguanosine), and lipid peroxides (malondialdehyde). Moreover, it caused a noticeable decline in the hepatic antioxidant indices (total antioxidant capacity and reduced glutathione content) and acetylcholinesterase activity. The hepatic, renal, and brain architectures were severely damaged by the C. albicans challenge, exhibiting significant fatty changes, necrosis, vacuolation, and congestion. Remarkably, the aqueous application of NCG in the C. albicans-challenged fish ameliorated all the aforementioned biomarkers and facilitated the regeneration of histopathological changes.

CONCLUSION: Overall, the application of NCG in the aquatic environment is an effective tool for managing C. albicans infection in Nile tilapia. Moreover, it can be utilized in combating stress conditions in the aquaculture sector.

BACKGROUND: Candida albicans infection induces economic losses in aquaculture practices. Currently, the success of the nanotechnology field has gained more consideration in the aquaculture sector as it bestows favorable impacts in remedies in comparison to traditional practices.

OBJECTIVE: The present study was conducted to assess the role of nano chitosan gel (NCG) exposure via water in managing the deteriorating impacts triggered by C. albicans in Nile tilapia, Oreochromis niloticus. Hepato-renal function, behavioral and stress response, neurological function, hepatic antioxidant/oxidant status, and histopathological architectures were investigated.

METHODS: A total of 160 fish (average weight: 50.00 ± 6.30 g) were randomly assigned to four groups, each with four replicates: control, NCG, C. albicans, and NCG + C. albicans. The NCG was applied as bath treatment at a concentration of 75 µg/L for ten days.

RESULTS: The outcomes demonstrated that the C. albicans challenged fish exhibited obvious behavioral alterations including loss of equilibrium, surfacing, abnormal swimming and movement, and aggression. Infection with C. albicans caused an elevation in hepato-renal biomarkers (alanine and aspartate aminotransferases, alkaline phosphatase, urea, and creatinine), stress-related indices (glucose, cortisol, nor-epinephrine, and 8-hydroxy-2-deoxyguanosine), and lipid peroxides (malondialdehyde). Moreover, it caused a noticeable decline in the hepatic antioxidant indices (total antioxidant capacity and reduced glutathione content) and acetylcholinesterase activity. The hepatic, renal, and brain architectures were severely damaged by the C. albicans challenge, exhibiting significant fatty changes, necrosis, vacuolation, and congestion. Remarkably, the aqueous application of NCG in the C. albicans-challenged fish ameliorated all the aforementioned biomarkers and facilitated the regeneration of histopathological changes.

CONCLUSION: Overall, the application of NCG in the aquatic environment is an effective tool for managing C. albicans infection in Nile tilapia. Moreover, it can be utilized in combating stress conditions in the aquaculture sector.

BACKGROUND: Candida albicans infection induces economic losses in aquaculture practices. Currently, the success of the nanotechnology field has gained more consideration in the aquaculture sector as it bestows favorable impacts in remedies in comparison to traditional practices.

OBJECTIVE: The present study was conducted to assess the role of nano chitosan gel (NCG) exposure via water in managing the deteriorating impacts triggered by C. albicans in Nile tilapia, Oreochromis niloticus. Hepato-renal function, behavioral and stress response, neurological function, hepatic antioxidant/oxidant status, and histopathological architectures were investigated.

METHODS: A total of 160 fish (average weight: 50.00 ± 6.30 g) were randomly assigned to four groups, each with four replicates: control, NCG, C. albicans, and NCG + C. albicans. The NCG was applied as bath treatment at a concentration of 75 µg/L for ten days.

RESULTS: The outcomes demonstrated that the C. albicans challenged fish exhibited obvious behavioral alterations including loss of equilibrium, surfacing, abnormal swimming and movement, and aggression. Infection with C. albicans caused an elevation in hepato-renal biomarkers (alanine and aspartate aminotransferases, alkaline phosphatase, urea, and creatinine), stress-related indices (glucose, cortisol, nor-epinephrine, and 8-hydroxy-2-deoxyguanosine), and lipid peroxides (malondialdehyde). Moreover, it caused a noticeable decline in the hepatic antioxidant indices (total antioxidant capacity and reduced glutathione content) and acetylcholinesterase activity. The hepatic, renal, and brain architectures were severely damaged by the C. albicans challenge, exhibiting significant fatty changes, necrosis, vacuolation, and congestion. Remarkably, the aqueous application of NCG in the C. albicans-challenged fish ameliorated all the aforementioned biomarkers and facilitated the regeneration of histopathological changes.

CONCLUSION: Overall, the application of NCG in the aquatic environment is an effective tool for managing C. albicans infection in Nile tilapia. Moreover, it can be utilized in combating stress conditions in the aquaculture sector.

Renal cell carcinoma (RCC) is a malignant neoplasm arising from the renal epithelium and constitutes approximately 2% of global cancer diagnoses and mortalities. With increasing prevalence, RCC remains a pressing clinical challenge, particularly because of its resistance to conventional therapies and poor outcomes in advanced stages. Long noncoding RNAs (lncRNAs) have been proposed as key molecular mediators in RCC, orchestrating critical pathways such as epithelial-to-mesenchymal transition (EMT), cellular proliferation, apoptosis, angiogenesis, and metastasis. Their roles in therapeutic resistance, including chemoresistance and radioresistance, further highlight their impact on treatment outcomes. Additionally, the potential of natural compounds such as curcumin, quercetin, and resveratrol to target lncRNA-mediated pathways has garnered attention, offering insights into novel therapeutic strategies. This review examines the biogenic pathways and multifaceted functions of lncRNAs, shedding light on their influence on RCC pathophysiology and posttranscriptional regulation. In addition, this review emphasizes the repercussions of natural compounds as lncRNA-targeted therapies, thus offering a comprehensive perspective on emerging strategies that may lead to more effective and personalized treatments.

Globally, the incidence and death rates associated with cancer persist in rising, despite considerable advancements in cancer therapy. Although some malignancies are manageable by a mix of chemotherapy, surgery, radiation, and targeted therapy, most malignant tumors either exhibit poor responsiveness to early identification or endure post-treatment survival. The prognosis for prostate cancer (PCa) is unfavorable since it is a perilous and lethal malignancy. The capacity of phytochemical and nutraceutical chemicals to repress oncogenic lncRNAs and activate tumor suppressor lncRNAs has garnered significant attention as a possible strategy to diminish the development, proliferation, metastasis, and invasion of cancer cells. A potential technique to treat cancer and enhance the sensitivity of cancer cells to existing conventional therapies is the use of phytochemicals with anticancer characteristics. Functional studies indicate that lncRNAs modulate drug resistance, stemness, invasion, metastasis, angiogenesis, and proliferation via interactions with tumor suppressors and oncoproteins. Among them, numerous lncRNAs, such as HOTAIR, PlncRNA1, GAS5, MEG3, LincRNA-21, and POTEF-AS1, support the development of PCa through many molecular mechanisms, including modulation of tumor suppressors and regulation of various signal pathways like PI3K/Akt, Bax/Caspase 3, P53, MAPK cascade, and TGF-β1. Other lncRNAs, in particular, MALAT-1, CCAT2, DANCR, LncRNA-ATB, PlncRNA1, LincRNA-21, POTEF-AS1, ZEB1-AS1, SChLAP1, and H19, are key players in regulating the aforementioned processes. Natural substances have shown promising anticancer benefits against PCa by altering essential signaling pathways. The overexpression of some lncRNAs is associated with advanced TNM stage, metastasis, chemoresistance, and reduced survival. LncRNAs possess crucial clinical and transitional implications in PCa, as diagnostic and prognostic biomarkers, as well as medicinal targets. To impede the progression of PCa, it is beneficial to target aberrant long non-coding RNAs using antisense oligonucleotides or small interfering RNAs (siRNAs). This prevents them from transmitting harmful messages. In summary, several precision medicine approaches may be used to rectify dysfunctional lncRNA regulatory circuits, so improving early PCa detection and eventually facilitating the conquest of this lethal disease. Due to their presence in biological fluids and tissues, they may serve as novel biomarkers. Enhancing PCa treatments mitigates resistance to chemotherapy and radiation.